The Swiss parent company of Atrium Medical Corp., Getinge, is facing nearly 900 hernia mesh lawsuits by people alleging their C-Qur™ surgical mesh is defective, and the company failed to warn of severe complications and side effects from their hernia mesh implant.
Patients are seeking compensation for complications and injuries suffered after receiving Atrium’s C-Qur hernia mesh implants. The company set aside the $200 million to cover the ongoing costs of litigation and future hernia mesh settlements.
The company also disclosed it has liability insurance, which may cover the costs of some or all of these abdominal hernia mesh lawsuits.
In October 2013, the Food and Drug Administration issued a recall of certain C-Qur surgical mesh devices.
The Atrium lawsuits, along with thousands of other hernia mesh lawsuits, were filed by individual patients in state and federal courts throughout the U.S. and Canada. The U.S.-based federal court lawsuits were later consolidated in multi-district federal litigation in Georgia.
The first jury trials from these hernia mesh lawsuits are expected to go forward in late 2019.
Atrium Medical manufactured the C-Qur hernia mesh implants at issue in the lawsuits. Getinge acquired Atrium Medical in 2011.
